Therapeutic potential of interleukin-2 in autoimmune diseases: Trends in Molecular Medicine
Figure 1 | Type I Diabetes-Associated Tolerogenic Properties of Interleukin- 2
The Surprising Story of IL-2 - The American Journal of Pathology
Article: Clinical significance of soluble interleukin-2 receptor measurement in immune-mediated diseases (full text) - September 2020 - NJM
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Diabetes & Endocrinology
Figure 2 | Type I Diabetes-Associated Tolerogenic Properties of Interleukin- 2
Acquired Defect in Interleukin-2 Production in Patients with Type I Diabetes Mellitus | NEJM
Kohlenhydratstoffwechsel Themen Typ 1 Diabetes als Autoimmunerkrankung Typ 1- Diabetes
Designer-Molekül gegen Typ-2-Diabetes: ärztliches journal
Insulin Receptor Substrate-2-dependent Interleukin-4 Signaling in Macrophages Is Impaired in Two Models of Type 2 Diabetes Mellitus* - Journal of Biological Chemistry
Projekt Julia, Katharina und Heinz ǀ UKD
Interleukin-1 Receptor Antagonist: A New Therapy for Type 2 Diabetes Mellitus - ScienceDirect
Genetic polymorphisms of cytokine genes in type 2 diabetes mellitus
Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune Hepatitis | SpringerLink
Activation of inflammasomes in type 2 diabetes (metabolic stress... | Download Scientific Diagram
![PDF] Central Role for Interleukin-2 in Type 1 Diabetes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9bbdf7240373d1a2a33a93571f5119ff3b51e311/5-Figure4-1.png "PDF] Central Role for Interleukin-2 in Type 1 Diabetes | Semantic Scholar")
PDF] Central Role for Interleukin-2 in Type 1 Diabetes | Semantic Scholar
The role of interleukin-2 during homeostasis and activation of the immune system | Nature Reviews Immunology
The role of interleukin-2 during homeostasis and activation of the immune system | Nature Reviews Immunology
Diabetes mellitus Typ 2
Acquired Defect in Interleukin-2 Production in Patients with Type I Diabetes Mellitus | NEJM
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial - The Lancet Diabetes & Endocrinology
The role of interleukins in insulin resistance and type 2 diabetes mellitus | Nature Reviews Endocrinology
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases | Nature Reviews Immunology
Neue Behandlungsmethode für Diabetes Typ 1 Patienten (Erstdiagnose) - Studie
The levels of interleukin-2 and interleukin-10 in patients with type 2 diabetes and colon cancer
![PDF] Central Role for Interleukin-2 in Type 1 Diabetes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9bbdf7240373d1a2a33a93571f5119ff3b51e311/2-Figure1-1.png "PDF] Central Role for Interleukin-2 in Type 1 Diabetes | Semantic Scholar")
PDF] Central Role for Interleukin-2 in Type 1 Diabetes | Semantic Scholar
